Read how we organised transcontinental travel and an extended stay for the family of a child participating in a neurological disorder trial during the peak of the COVID-19 pandemic.

During the coronavirus pandemic we made alternative arrangements for a patient visit where the patient was not comfortable travelling to the clinical trial site and did not want study staff in their home.

A clinical-stage biopharmaceutical company wanted to hold a previously scheduled face-to-face investigator meeting on a virtual platform, allowing those who were scheduled to attend in person to still be trained.